<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37907497</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2059-3635</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Signal transduction and targeted therapy</Title><ISOAbbreviation>Signal Transduct Target Ther</ISOAbbreviation></Journal><ArticleTitle>The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID.</ArticleTitle><Pagination><StartPage>416</StartPage><MedlinePgn>416</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">416</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41392-023-01640-z</ELocationID><Abstract><AbstractText>There have been hundreds of millions of cases of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With the growing population of recovered patients, it is crucial to understand the long-term consequences of the disease and management strategies. Although COVID-19 was initially considered an acute respiratory illness, recent evidence suggests that manifestations including but not limited to those of the cardiovascular, respiratory, neuropsychiatric, gastrointestinal, reproductive, and musculoskeletal systems may persist long after the acute phase. These persistent manifestations, also referred to as long COVID, could impact all patients with COVID-19 across the full spectrum of illness severity. Herein, we comprehensively review the current literature on long COVID, highlighting its epidemiological understanding, the impact of vaccinations, organ-specific sequelae, pathophysiological mechanisms, and multidisciplinary management strategies. In addition, the impact of psychological and psychosomatic factors is also underscored. Despite these crucial findings on long COVID, the current diagnostic and therapeutic strategies based on previous experience and pilot studies remain inadequate, and well-designed clinical trials should be prioritized to validate existing hypotheses. Thus, we propose the primary challenges concerning biological knowledge gaps and efficient remedies as well as discuss the corresponding recommendations.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Jingwei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Med-X Center for Manufacturing, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhou</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Med-X Center for Manufacturing, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ma</LastName><ForeName>Jiechao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>AI Lab, Deepwise Healthcare, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Qin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Med-X Center for Manufacturing, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Postgraduate Student, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Med-X Center for Manufacturing, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Shufan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Med-X Center for Manufacturing, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yizhou</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-0470-5548</Identifier><AffiliationInfo><Affiliation>Department of Computer Science, The University of Hong Kong, Hong Kong, China. yizhouy@acm.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Weimin</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-0985-0311</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Med-X Center for Manufacturing, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China. weimi003@scu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chengdi</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-5284-2889</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Med-X Center for Manufacturing, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China. chengdi_wang@scu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021M692309, 2022T150451</GrantID><Agency>China Postdoctoral Science Foundation</Agency><Country/></Grant><Grant><GrantID>2020HXBH084, CGZH21009</GrantID><Agency>Sichuan University (SCU)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Signal Transduct Target Ther</MedlineTA><NlmUniqueID>101676423</NlmUniqueID><ISSNLinking>2059-3635</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>W.L. is one of the Associate Editors of Signal Transduction and Targeted Therapy, but he has not been involved in the process of the manuscript handling. All authors listed declared that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>2</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37907497</ArticleId><ArticleId IdType="pmc">PMC10618229</ArticleId><ArticleId IdType="doi">10.1038/s41392-023-01640-z</ArticleId><ArticleId IdType="pii">10.1038/s41392-023-01640-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Halperin SA, et al. Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial. Lancet. 2022;399:237&#x2013;248. doi: 10.1016/S0140-6736(21)02753-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02753-7</ArticleId><ArticleId IdType="pmc">PMC8700283</ArticleId><ArticleId IdType="pubmed">34953526</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Shao J, Wang C, Li W. The epidemiology and therapeutic options for the COVID-19. Precis. Clin. Med. 2020;3:71&#x2013;84. doi: 10.1093/pcmedi/pbaa017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pcmedi/pbaa017</ArticleId><ArticleId IdType="pmc">PMC7376264</ArticleId><ArticleId IdType="pubmed">35960683</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. WHO coronavirus (COVID-19) dashboard, https://covid19.who.int (2023).</Citation></Reference><Reference><Citation>Wang C, et al. COVID-19 in early 2021: current status and looking forward. Signal Transduct. Target Ther. 2021;6:114. doi: 10.1038/s41392-021-00527-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00527-1</ArticleId><ArticleId IdType="pmc">PMC7938042</ArticleId><ArticleId IdType="pubmed">33686059</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, et al. Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management. J. Transl. Int. Med. 2020;8:9&#x2013;19. doi: 10.2478/jtim-2020-0003.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/jtim-2020-0003</ArticleId><ArticleId IdType="pmc">PMC7227161</ArticleId><ArticleId IdType="pubmed">32435607</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. doi: 10.1136/bmj.m1091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1091</ArticleId><ArticleId IdType="pmc">PMC7190011</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of COVID-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, et al. Long COVID-an update for primary care. BMJ. 2022;378:e072117. doi: 10.1136/bmj-2022-072117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072117</ArticleId><ArticleId IdType="pubmed">36137612</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am. J. Gastroenterol. 2020;115:766&#x2013;773. doi: 10.14309/ajg.0000000000000620.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000620</ArticleId><ArticleId IdType="pmc">PMC7172492</ArticleId><ArticleId IdType="pubmed">32287140</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31:100683. doi: 10.1016/j.eclinm.2020.100683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100683</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Naeije R, Caravita S. Phenotyping long COVID. Eur. Respir. J. 2021;58:2101763. doi: 10.1183/13993003.01763-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01763-2021</ArticleId><ArticleId IdType="pmc">PMC8287735</ArticleId><ArticleId IdType="pubmed">34244323</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, et al. Long COVID in the Faroe Islands: a longitudinal study among nonhospitalized patients. Clin. Infect. Dis. 2021;73:e4058&#x2013;e4063. doi: 10.1093/cid/ciaa1792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Risks and burdens of incident dyslipidaemia in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2023;11:120&#x2013;128. doi: 10.1016/S2213-8587(22)00355-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00355-2</ArticleId><ArticleId IdType="pmc">PMC9873268</ArticleId><ArticleId IdType="pubmed">36623520</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan BKJ, et al. Prognosis and persistence of smell and taste dysfunction in patients with COVID-19: meta-analysis with parametric cure modelling of recovery curves. BMJ. 2022;378:e069503. doi: 10.1136/bmj-2021-069503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069503</ArticleId><ArticleId IdType="pmc">PMC9326326</ArticleId><ArticleId IdType="pubmed">35896188</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker AM, et al. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care. Lancet Respir. Med. 2021;9:1328&#x2013;1341. doi: 10.1016/S2213-2600(21)00385-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00385-4</ArticleId><ArticleId IdType="pmc">PMC8525917</ArticleId><ArticleId IdType="pubmed">34678213</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran VT, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat. Commun. 2022;13:1812. doi: 10.1038/s41467-022-29513-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Seessle J, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin. Infect Dis. 2022;74:1191&#x2013;1198. doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow AJ, et al. A multisystem, cardio-renal investigation of post-COVID-19 illness. Nat. Med. 2022;28:1303&#x2013;1313. doi: 10.1038/s41591-022-01837-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01837-9</ArticleId><ArticleId IdType="pmc">PMC9205780</ArticleId><ArticleId IdType="pubmed">35606551</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif ZA, et al. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC) Elife. 2023;12:e86002. doi: 10.7554/eLife.86002.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86002</ArticleId><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Osiaevi I, et al. Persistent capillary rarefication in long COVID syndrome. Angiogenesis. 2023;26:53&#x2013;61. doi: 10.1007/s10456-022-09850-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-022-09850-9</ArticleId><ArticleId IdType="pmc">PMC9366128</ArticleId><ArticleId IdType="pubmed">35951203</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022;10:863&#x2013;876. doi: 10.1016/S2213-2600(22)00126-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin. Microbiol. Infect. 2021;27:258&#x2013;263. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Perez O, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J. Infect. 2021;82:378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J. Med. Virol. 2021;93:1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, et al. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400:452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021;76:399&#x2013;401. doi: 10.1136/thoraxjnl-2020-216086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunster C, et al. 6-month mortality and readmissions of hospitalized COVID-19 patients: a nationwide cohort study of 8,679 patients in Germany. PLoS One. 2021;16:e0255427. doi: 10.1371/journal.pone.0255427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0255427</ArticleId><ArticleId IdType="pmc">PMC8341502</ArticleId><ArticleId IdType="pubmed">34351975</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, et al. Sixty-day outcomes among patients hospitalized with COVID-19. Ann. Intern. Med. 2021;174:576&#x2013;578. doi: 10.7326/M20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L, et al. Post-COVID conditions among adult COVID-19 survivors aged 18-64 and &#x2265; 65 years - United States, March 2020-November 2021. MMWR Morbidity Mortality Wkly Rep. 2022;71:713&#x2013;717. doi: 10.15585/mmwr.mm7121e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long, C. C. et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604&#x2013;1615. doi: 10.1001/jama.2022.18931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Righi E, et al. Determinants of persistence of symptoms and impact on physical and mental wellbeing in long COVID: a prospective cohort study. J. Infect. 2022;84:566&#x2013;572. doi: 10.1016/j.jinf.2022.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.02.003</ArticleId><ArticleId IdType="pmc">PMC8828388</ArticleId><ArticleId IdType="pubmed">35150765</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam GY, et al. COVID-19 hospitalization is associated with pulmonary/diffusion abnormalities but not post-acute sequelae of COVID-19 severity. J. Intern. Med. 2022;291:694&#x2013;697. doi: 10.1111/joim.13427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13427</ArticleId><ArticleId IdType="pubmed">34875129</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022;399:1618&#x2013;1624. doi: 10.1016/S0140-6736(22)00327-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00327-0</ArticleId><ArticleId IdType="pmc">PMC8989396</ArticleId><ArticleId IdType="pubmed">35397851</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyre DW, et al. Effect of COVID-19 vaccination on transmission of Alpha and Delta variants. N. Engl J. Med. 2022;386:744&#x2013;756. doi: 10.1056/NEJMoa2116597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2116597</ArticleId><ArticleId IdType="pmc">PMC8757571</ArticleId><ArticleId IdType="pubmed">34986294</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, et al. Long COVID-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B, et al. Long COVID outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ. 2023;380:e072529. doi: 10.1136/bmj-2022-072529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, et al. Associated-onset symptoms and post-COVID-19 symptoms in hospitalized COVID-19 survivors infected with Wuhan, Alpha or Delta SARS-CoV-2 variant. Pathogens. 2022;11:725. doi: 10.3390/pathogens11070725.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11070725</ArticleId><ArticleId IdType="pmc">PMC9320021</ArticleId><ArticleId IdType="pubmed">35889971</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, et al. Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: a systematic review of the literature. Viruses. 2022;14:2629. doi: 10.3390/v14122629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun MC, et al. Long COVID following Omicron wave in Eastern India-a retrospective cohort study. J. Med. Virol. 2023;95:e28214. doi: 10.1002/jmv.28214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28214</ArticleId><ArticleId IdType="pmc">PMC9874641</ArticleId><ArticleId IdType="pubmed">36224705</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, et al. Risk of long COVID associated with Delta versus Omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Torjesen I. COVID-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear. BMJ. 2021;375:n2943. doi: 10.1136/bmj.n2943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n2943</ArticleId><ArticleId IdType="pubmed">34845008</ArticleId></ArticleIdList></Reference><Reference><Citation>Tregoning JS, et al. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat. Rev. Immunol. 2021;21:626&#x2013;636. doi: 10.1038/s41577-021-00592-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00592-1</ArticleId><ArticleId IdType="pmc">PMC8351583</ArticleId><ArticleId IdType="pubmed">34373623</ArticleId></ArticleIdList></Reference><Reference><Citation>Grewal R, et al. Effectiveness of a fourth dose of COVID-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study. BMJ. 2022;378:e071502. doi: 10.1136/bmj-2022-071502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-071502</ArticleId><ArticleId IdType="pmc">PMC9257064</ArticleId><ArticleId IdType="pubmed">35793826</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, et al. Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw. Open. 2022;5:e2238804. doi: 10.1001/jamanetworkopen.2022.38804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, et al. Trajectory of long COVID symptoms after COVID-19 vaccination: community based cohort study. BMJ. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E, et al. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA. 2022;328:676&#x2013;678. doi: 10.1001/jama.2022.11691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav. Immun. 2022;103:154&#x2013;162. doi: 10.1016/j.bbi.2022.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Meza-Torres B, et al. Differences in clinical presentation with long COVID after community and hospital infection and associations with all-cause mortality: English sentinel network database study. JMIR Public Health Surveill. 2022;8:e37668. doi: 10.2196/37668.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/37668</ArticleId><ArticleId IdType="pmc">PMC9384859</ArticleId><ArticleId IdType="pubmed">35605170</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchida T, et al. Relationship between changes in symptoms and antibody titers after a single vaccination in patients with long COVID. J. Med. Virol. 2022;94:3416&#x2013;3420. doi: 10.1002/jmv.27689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27689</ArticleId><ArticleId IdType="pmc">PMC9088489</ArticleId><ArticleId IdType="pubmed">35238053</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat. Med. 2022;28:2398&#x2013;2405. doi: 10.1038/s41591-022-02051-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordstrom P, Ballin M, Nordstrom A. Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden. Lancet Infect. Dis. 2022;22:781&#x2013;790. doi: 10.1016/S1473-3099(22)00143-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00143-8</ArticleId><ArticleId IdType="pmc">PMC8971363</ArticleId><ArticleId IdType="pubmed">35366962</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S, Nath A. Nervous system consequences of COVID-19. Science. 2022;375:267&#x2013;269. doi: 10.1126/science.abm2052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Almufarrij I, Munro KJ. One year on: an updated systematic review of SARS-CoV-2, COVID-19 and audio-vestibular symptoms. Int. J. Audiol. 2021;60:935&#x2013;945. doi: 10.1080/14992027.2021.1896793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14992027.2021.1896793</ArticleId><ArticleId IdType="pubmed">33750252</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8:130&#x2013;140. doi: 10.1016/S2215-0366(20)30462-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota T, Kuroda N, Sone D. Neuropsychiatric aspects of long COVID: a comprehensive review. Psychiatry Clin. Neurosci. 2023;77:84&#x2013;93. doi: 10.1111/pcn.13508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.13508</ArticleId><ArticleId IdType="pmc">PMC10108156</ArticleId><ArticleId IdType="pubmed">36385449</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JW, Wang X, Xu RH. Revealing the mystery of persistent smell loss in long COVID patients. Int. J. Biol. Sci. 2022;18:4795&#x2013;4808. doi: 10.7150/ijbs.73485.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.73485</ArticleId><ArticleId IdType="pmc">PMC9305264</ArticleId><ArticleId IdType="pubmed">35874953</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27:1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, et al. Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Montine TJ, Bukhari SA, White LR. Cognitive impairment in older adults and therapeutic strategies. Pharmacol. Rev. 2021;73:152&#x2013;162. doi: 10.1124/pharmrev.120.000031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pharmrev.120.000031</ArticleId><ArticleId IdType="pmc">PMC7736830</ArticleId><ArticleId IdType="pubmed">33298513</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao J, Frankland PW. COVID fog demystified. Cell. 2022;185:2391&#x2013;2393. doi: 10.1016/j.cell.2022.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.020</ArticleId><ArticleId IdType="pmc">PMC9197953</ArticleId><ArticleId IdType="pubmed">35768007</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker JH, et al. Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw. Open. 2021;4:e2130645. doi: 10.1001/jamanetworkopen.2021.30645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.30645</ArticleId><ArticleId IdType="pmc">PMC8536953</ArticleId><ArticleId IdType="pubmed">34677597</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022;9:815&#x2013;827. doi: 10.1016/S2215-0366(22)00260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang BZ, et al. SARS-CoV-2 infects human neural progenitor cells and brain organoids. Cell Res. 2020;30:928&#x2013;931. doi: 10.1038/s41422-020-0390-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0390-x</ArticleId><ArticleId IdType="pmc">PMC7399356</ArticleId><ArticleId IdType="pubmed">32753756</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkai I, et al. Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat. Commun. 2022;13:1745. doi: 10.1038/s41467-022-29440-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29440-z</ArticleId><ArticleId IdType="pmc">PMC8975902</ArticleId><ArticleId IdType="pubmed">35365631</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Charnley M, et al. Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19. Nat. Commun. 2022;13:3387. doi: 10.1038/s41467-022-30932-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30932-1</ArticleId><ArticleId IdType="pmc">PMC9189797</ArticleId><ArticleId IdType="pubmed">35697699</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM. Differential diagnosis and pathogenesis of the neurological signs and symptoms in COVID-19 and long-COVID syndrome. CNS Neurosci. Ther. 2022;28:1905&#x2013;1907. doi: 10.1111/cns.13957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13957</ArticleId><ArticleId IdType="pmc">PMC9539369</ArticleId><ArticleId IdType="pubmed">36117492</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Heine J, et al. Structural brain changes in patients with post-COVID fatigue: a prospective observational study. EClinicalMedicine. 2023;58:101874. doi: 10.1016/j.eclinm.2023.101874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101874</ArticleId><ArticleId IdType="pmc">PMC9969172</ArticleId><ArticleId IdType="pubmed">36873426</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Castaneda A, et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185:2452&#x2013;2468.e2416. doi: 10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataramani V, Winkler F. Cognitive deficits in long COVID-19. N. Engl. J. Med. 2022;387:1813&#x2013;1815. doi: 10.1056/NEJMcibr2210069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2210069</ArticleId><ArticleId IdType="pubmed">36351274</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiken S, et al. Alzheimer&#x2019;s-like signaling in brains of COVID-19 patients. Alzheimers Dement. 2022;18:955&#x2013;965. doi: 10.1002/alz.12558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12558</ArticleId><ArticleId IdType="pmc">PMC9011576</ArticleId><ArticleId IdType="pubmed">35112786</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere JJ, et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci. Transl. Med. 2022;14:eabq3059. doi: 10.1126/scitranslmed.abq3059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq3059</ArticleId><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Szewczykowski C, et al. Long COVID: association of functional autoantibodies against G-protein-coupled receptors with an impaired retinal microcirculation. Int. J. Mol. Sci. 2022;23:7209. doi: 10.3390/ijms23137209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23137209</ArticleId><ArticleId IdType="pmc">PMC9266742</ArticleId><ArticleId IdType="pubmed">35806214</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J. Thromb. Haemost. 2021;19:2546&#x2013;2553. doi: 10.1111/jth.15490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou E, et al. Endothelial dysfunction in acute and long standing COVID-19: a prospective cohort study. Vascul. Pharmacol. 2022;144:106975. doi: 10.1016/j.vph.2022.106975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2022.106975</ArticleId><ArticleId IdType="pmc">PMC8893931</ArticleId><ArticleId IdType="pubmed">35248780</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat. Med. 2022;28:911&#x2013;923. doi: 10.1038/s41591-022-01810-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. 1994;121:953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol. Med. 2021;27:895&#x2013;906. doi: 10.1016/j.molmed.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein L, Wong KK, Kallen AJ, Uyeki TM. Post-Ebola signs and symptoms in U.S. survivors. N. Engl. J. Med. 2015;373:2484&#x2013;2486. doi: 10.1056/NEJMc1506576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1506576</ArticleId><ArticleId IdType="pubmed">26672870</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones JF, et al. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann. Intern. Med. 1985;102:1&#x2013;7. doi: 10.7326/0003-4819-102-1-.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-102-1-</ArticleId><ArticleId IdType="pubmed">2578266</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL. Is human herpesvirus-6 a trigger for chronic fatigue syndrome? J. Clin. Virol. 2006;37:S39&#x2013;S46. doi: 10.1016/S1386-6532(06)70010-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1386-6532(06)70010-5</ArticleId><ArticleId IdType="pubmed">17276367</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Salit IE. Sporadic postinfectious neuromyasthenia. CMAJ. 1985;133:659&#x2013;663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1346266</ArticleId><ArticleId IdType="pubmed">4042036</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-a systemic review and comparison of clinical presentation and symptomatology. Medicina. 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey R, et al. Chronic fatigue and postexertional malaise in people living with long COVID: an observational study. Phys. Ther. 2022;102:pzac005. doi: 10.1093/ptj/pzac005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzac005</ArticleId><ArticleId IdType="pmc">PMC9383197</ArticleId><ArticleId IdType="pubmed">35079817</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorg AL, et al. Association of SARS-CoV-2 seropositivity with myalgic encephalomyelitis and/or chronic fatigue syndrome among children and adolescents in Germany. JAMA Netw. Open. 2022;5:e2233454. doi: 10.1001/jamanetworkopen.2022.33454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.33454</ArticleId><ArticleId IdType="pmc">PMC9516317</ArticleId><ArticleId IdType="pubmed">36166227</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge O, Tronstad KJ, Mella O. Pathomechanisms and possible interventions in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J. Clin. Invest. 2021;131:e150377. doi: 10.1172/JCI150377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI150377</ArticleId><ArticleId IdType="pmc">PMC8279575</ArticleId><ArticleId IdType="pubmed">34263741</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Z, Li S, Song X. Cytokine storm with rapidly elevated interleukin-6 indicates sudden death in patients with critical COVID-19. Cytokine Growth Factor Rev. 2021;58:30&#x2013;31. doi: 10.1016/j.cytogfr.2020.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.08.001</ArticleId><ArticleId IdType="pmc">PMC7445135</ArticleId><ArticleId IdType="pubmed">32873506</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv Y, et al. Bioinformatics and systems biology approach to identify the pathogenetic link of long COVID and myalgic encephalomyelitis/chronic fatigue syndrome. Front. Immunol. 2022;13:952987. doi: 10.3389/fimmu.2022.952987.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.952987</ArticleId><ArticleId IdType="pmc">PMC9524193</ArticleId><ArticleId IdType="pubmed">36189286</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M, et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2022;20:138. doi: 10.1186/s12967-022-03346-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Resendiz KJG, et al. Loss of mitochondrial membrane potential (DeltaPsi(m)) in leucocytes as post-COVID-19 sequelae. J. Leukoc. Biol. 2022;112:23&#x2013;29. doi: 10.1002/JLB.3MA0322-279RRR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3MA0322-279RRR</ArticleId><ArticleId IdType="pmc">PMC9088601</ArticleId><ArticleId IdType="pubmed">35355308</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntur VP, et al. Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of COVID-19 (PASC) Metabolites. 2022;12:1026. doi: 10.3390/metabo12111026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12111026</ArticleId><ArticleId IdType="pmc">PMC9699059</ArticleId><ArticleId IdType="pubmed">36355108</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogl T, et al. Systemic antibody responses against human microbiota flagellins are overrepresented in chronic fatigue syndrome patients. Sci. Adv. 2022;8:eabq2422. doi: 10.1126/sciadv.abq2422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abq2422</ArticleId><ArticleId IdType="pubmed">36149952</ArticleId></ArticleIdList></Reference><Reference><Citation>Bragee B, et al. Signs of intracranial hypertension, hypermobility, and craniocervical obstructions in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Front. Neurol. 2020;11:828. doi: 10.3389/fneur.2020.00828.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00828</ArticleId><ArticleId IdType="pmc">PMC7485557</ArticleId><ArticleId IdType="pubmed">32982905</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoad A, Spickett G, Elliott J, Newton J. Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome. QJM. 2008;101:961&#x2013;965. doi: 10.1093/qjmed/hcn123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcn123</ArticleId><ArticleId IdType="pubmed">18805903</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB, et al. Mast cell activation symptoms are prevalent in long-COVID. Int. J. Infect. Dis. 2021;112:217&#x2013;226. doi: 10.1016/j.ijid.2021.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, et al. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect. Dis. 2021;21:1373&#x2013;1382. doi: 10.1016/S1473-3099(21)00211-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00211-5</ArticleId><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A, Sutton R. Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome. Nat. Rev. Cardiol. 2023;20:281&#x2013;282. doi: 10.1038/s41569-023-00842-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-023-00842-w</ArticleId><ArticleId IdType="pmc">PMC9893964</ArticleId><ArticleId IdType="pubmed">36732397</ArticleId></ArticleIdList></Reference><Reference><Citation>Aikawa T, Takagi H, Ishikawa K, Kuno T. Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis. J. Med. Virol. 2021;93:51&#x2013;55. doi: 10.1002/jmv.26108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26108</ArticleId><ArticleId IdType="pmc">PMC7301031</ArticleId><ArticleId IdType="pubmed">32484975</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, Luscher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 2022;43:1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini D, et al. Microthrombi as a major cause of cardiac injury in COVID-19: a pathologic study. Circulation. 2021;143:1031&#x2013;1042. doi: 10.1161/CIRCULATIONAHA.120.051828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.051828</ArticleId><ArticleId IdType="pubmed">33480806</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, et al. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc. Res. 2020;116:1097&#x2013;1100. doi: 10.1093/cvr/cvaa078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa078</ArticleId><ArticleId IdType="pmc">PMC7184507</ArticleId><ArticleId IdType="pubmed">32227090</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan AO, et al. Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculature. Cardiovasc. Res. 2022;118:3085&#x2013;3096. doi: 10.1093/cvr/cvac097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvac097</ArticleId><ArticleId IdType="pmc">PMC9214165</ArticleId><ArticleId IdType="pubmed">35709328</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina F, et al. Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect. Dis. 2022;22:211. doi: 10.1186/s12879-022-07153-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07153-4</ArticleId><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceulemans LJ, et al. Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19. Lancet Respir. Med. 2021;9:e78&#x2013;e79. doi: 10.1016/S2213-2600(21)00240-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00240-X</ArticleId><ArticleId IdType="pmc">PMC8189667</ArticleId><ArticleId IdType="pubmed">34118186</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e820. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Takakura K, Suka M, Kajihara M, Koido S. Clinical features, therapeutic outcomes, and recovery period of long COVID. J. Med. Virol. 2023;95:e28316. doi: 10.1002/jmv.28316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28316</ArticleId><ArticleId IdType="pmc">PMC10108287</ArticleId><ArticleId IdType="pubmed">36412057</ArticleId></ArticleIdList></Reference><Reference><Citation>Skinner JP, Moran LV. Persistent effects of COVID-19 in patients hospitalized during the first wave of the pandemic: the impact of persistent fatigue on quality of life in a cross-sectional study. J. Med. Virol. 2023;95:e28491. doi: 10.1002/jmv.28491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28491</ArticleId><ArticleId IdType="pubmed">36832543</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N. Engl. J. Med. 2020;383:120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JL, et al. Quantitative chest CT assessment of small airways disease in post-acute SARS-CoV-2 infection. Radiology. 2022;304:185&#x2013;192. doi: 10.1148/radiol.212170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.212170</ArticleId><ArticleId IdType="pmc">PMC9270680</ArticleId><ArticleId IdType="pubmed">35289657</ArticleId></ArticleIdList></Reference><Reference><Citation>McElvaney OJ, et al. Characterization of the inflammatory response to severe COVID-19 illness. Am. J. Respir. Crit. Care Med. 2020;202:812&#x2013;821. doi: 10.1164/rccm.202005-1583OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202005-1583OC</ArticleId><ArticleId IdType="pmc">PMC7491404</ArticleId><ArticleId IdType="pubmed">32584597</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B, et al. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity. 2022;55:542&#x2013;556.e545. doi: 10.1016/j.immuni.2022.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.017</ArticleId><ArticleId IdType="pmc">PMC8789571</ArticleId><ArticleId IdType="pubmed">35151371</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlefield KM, et al. SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog. 2022;18:e1010359. doi: 10.1371/journal.ppat.1010359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010359</ArticleId><ArticleId IdType="pmc">PMC9176759</ArticleId><ArticleId IdType="pubmed">35617421</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Meringer H, Mehandru S. Gastrointestinal post-acute COVID-19 syndrome. Nat. Rev. Gastroenterol. Hepatol. 2022;19:345&#x2013;346. doi: 10.1038/s41575-022-00611-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-022-00611-z</ArticleId><ArticleId IdType="pmc">PMC8981882</ArticleId><ArticleId IdType="pubmed">35383321</ArticleId></ArticleIdList></Reference><Reference><Citation>Marasco G, et al. Post COVID-19 irritable bowel syndrome. Gut. 2023;72:484&#x2013;492. doi: 10.1136/gutjnl-2022-328483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2022-328483</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, et al. Exploring the recovery curve for gastrointestinal symptoms from the acute COVID-19 phase to long-term post-COVID: the LONG-COVID-EXP-CM multicenter study. J. Med. Virol. 2022;94:2925&#x2013;2927. doi: 10.1002/jmv.27727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27727</ArticleId><ArticleId IdType="pmc">PMC9088575</ArticleId><ArticleId IdType="pubmed">35315087</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackett JW, Wainberg M, Elkind MSV, Freedberg DE. Potential long coronavirus disease 2019 gastrointestinal symptoms 6 months after coronavirus infection are associated with mental health symptoms. Gastroenterology. 2022;162:648&#x2013;650.e642. doi: 10.1053/j.gastro.2021.10.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.10.040</ArticleId><ArticleId IdType="pmc">PMC8556689</ArticleId><ArticleId IdType="pubmed">34728186</ArticleId></ArticleIdList></Reference><Reference><Citation>Joukar F, et al. Persistence of SARS-CoV-2 RNA in the nasopharyngeal, blood, urine, and stool samples of patients with COVID-19: a hospital-based longitudinal study. Virol. J. 2021;18:134. doi: 10.1186/s12985-021-01599-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-021-01599-9</ArticleId><ArticleId IdType="pmc">PMC8248752</ArticleId><ArticleId IdType="pubmed">34210325</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin. Infect. Dis. 2023;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, et al. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;163:495&#x2013;506 e498. doi: 10.1053/j.gastro.2022.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Weersma RK, Zhernakova A, Fu J. Interaction between drugs and the gut microbiome. Gut. 2020;69:1510&#x2013;1519. doi: 10.1136/gutjnl-2019-320204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2019-320204</ArticleId><ArticleId IdType="pmc">PMC7398478</ArticleId><ArticleId IdType="pubmed">32409589</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, et al. Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2022;7:143. doi: 10.1038/s41392-022-00986-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00986-0</ArticleId><ArticleId IdType="pmc">PMC9052735</ArticleId><ArticleId IdType="pubmed">35487886</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, et al. Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome. Nat. Commun. 2022;13:6806. doi: 10.1038/s41467-022-34535-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34535-8</ArticleId><ArticleId IdType="pmc">PMC9648868</ArticleId><ArticleId IdType="pubmed">36357381</ArticleId></ArticleIdList></Reference><Reference><Citation>Vestad B, et al. Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations. J. Intern. Med. 2022;291:801&#x2013;812. doi: 10.1111/joim.13458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13458</ArticleId><ArticleId IdType="pmc">PMC9115297</ArticleId><ArticleId IdType="pubmed">35212063</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanoli L, et al. Vascular dysfunction of COVID-19 is partially reverted in the long-term. Circ. Res. 2022;130:1276&#x2013;1285. doi: 10.1161/CIRCRESAHA.121.320460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.320460</ArticleId><ArticleId IdType="pubmed">35345906</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, et al. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, et al. Neurovascular injury with complement activation and inflammation in COVID-19. Brain. 2022;145:2555&#x2013;2568. doi: 10.1093/brain/awac151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac151</ArticleId><ArticleId IdType="pmc">PMC9278212</ArticleId><ArticleId IdType="pubmed">35788639</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I, et al. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after COVID-19: nationwide self-controlled cases series and matched cohort study. BMJ. 2022;377:e069590. doi: 10.1136/bmj-2021-069590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069590</ArticleId><ArticleId IdType="pmc">PMC8984137</ArticleId><ArticleId IdType="pubmed">35387772</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen EL, et al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: the Hamburg city health study COVID programme. Eur. Heart J. 2022;43:1124&#x2013;1137. doi: 10.1093/eurheartj/ehab914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab914</ArticleId><ArticleId IdType="pmc">PMC8755397</ArticleId><ArticleId IdType="pubmed">34999762</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11:e048391. doi: 10.1136/bmjopen-2020-048391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J. Hepatol. 2020;73:807&#x2013;816. doi: 10.1016/j.jhep.2020.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7211738</ArticleId><ArticleId IdType="pubmed">32437830</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayar M, et al. SARS-CoV-2 infection is associated with an increased risk of idiopathic acute pancreatitis but not pancreatic exocrine insufficiency or diabetes: long-term results of the COVIDPAN study. Gut. 2022;71:1444&#x2013;1447. doi: 10.1136/gutjnl-2021-326218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-326218</ArticleId><ArticleId IdType="pubmed">34764192</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, et al. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin. Gastroenterol. Hepatol. 2020;18:2128&#x2013;2130.e2122. doi: 10.1016/j.cgh.2020.04.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.04.040</ArticleId><ArticleId IdType="pmc">PMC7194639</ArticleId><ArticleId IdType="pubmed">32334082</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10:311&#x2013;321. doi: 10.1016/S2213-8587(22)00044-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Enghard P, et al. Long-term effects of COVID-19 on kidney function. Lancet. 2021;397:1806&#x2013;1807. doi: 10.1016/S0140-6736(21)00880-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00880-1</ArticleId><ArticleId IdType="pmc">PMC8118614</ArticleId><ArticleId IdType="pubmed">33992141</ArticleId></ArticleIdList></Reference><Reference><Citation>Yende S, Parikh CR. Long COVID and kidney disease. Nat. Rev. Nephrol. 2021;17:792&#x2013;793. doi: 10.1038/s41581-021-00487-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-021-00487-3</ArticleId><ArticleId IdType="pmc">PMC8427150</ArticleId><ArticleId IdType="pubmed">34504319</ArticleId></ArticleIdList></Reference><Reference><Citation>Phelan N, Behan LA, Owens L. The impact of the COVID-19 pandemic on women&#x2019;s reproductive health. Front. Endocrinol. 2021;12:642755. doi: 10.3389/fendo.2021.642755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.642755</ArticleId><ArticleId IdType="pmc">PMC8030584</ArticleId><ArticleId IdType="pubmed">33841334</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan SM, et al. SARS-CoV-2 infection and subsequent changes in the menstrual cycle among participants in the Arizona CoVHORT study. Am. J. Obstet. Gynecol. 2022;226:270&#x2013;273. doi: 10.1016/j.ajog.2021.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2021.09.016</ArticleId><ArticleId IdType="pmc">PMC8452349</ArticleId><ArticleId IdType="pubmed">34555320</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding T, et al. Analysis of ovarian injury associated with COVID-19 disease in reproductive-aged women in Wuhan, China: an observational study. Front. Med. 2021;8:635255. doi: 10.3389/fmed.2021.635255.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.635255</ArticleId><ArticleId IdType="pmc">PMC8017139</ArticleId><ArticleId IdType="pubmed">33816526</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrero Y, et al. SARS-CoV-2 infection negatively affects ovarian function in ART patients. Biochim. Biophys. Acta Mol. Basis Dis. 2022;1868:166295. doi: 10.1016/j.bbadis.2021.166295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2021.166295</ArticleId><ArticleId IdType="pmc">PMC8550892</ArticleId><ArticleId IdType="pubmed">34718118</ArticleId></ArticleIdList></Reference><Reference><Citation>Madendag IC, Madendag Y, Ozdemir AT. COVID-19 disease does not cause ovarian injury in women of reproductive age: an observational before-and-after COVID-19 study. Reprod. Biomed. Online. 2022;45:153&#x2013;158. doi: 10.1016/j.rbmo.2022.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rbmo.2022.03.002</ArticleId><ArticleId IdType="pmc">PMC8897265</ArticleId><ArticleId IdType="pubmed">35523708</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, et al. Effect of COVID-19 on male reproductive system - a systematic review. Front. Endocrinol. 2021;12:677701. doi: 10.3389/fendo.2021.677701.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.677701</ArticleId><ArticleId IdType="pmc">PMC8190708</ArticleId><ArticleId IdType="pubmed">34122351</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannur S, Jabeen T, Khader MA, Rao LSS. Post-COVID-19-associated decline in long-term male fertility and embryo quality during assisted reproductive technology. QJM. 2021;114:328&#x2013;330. doi: 10.1093/qjmed/hcab019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcab019</ArticleId><ArticleId IdType="pmc">PMC7928660</ArticleId><ArticleId IdType="pubmed">33508136</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID includes breathing and reproductive problems and has a range of risk factors. Nat Med. 28, 1554&#x2013;1555, (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9373893</ArticleId><ArticleId IdType="pubmed">35962207</ArticleId></ArticleIdList></Reference><Reference><Citation>Kresch E, et al. COVID-19 endothelial dysfunction can cause erectile dysfunction: histopathological, immunohistochemical, and ultrastructural study of the human penis. World J. Mens Health. 2021;39:466&#x2013;469. doi: 10.5534/wjmh.210055.</Citation><ArticleIdList><ArticleId IdType="doi">10.5534/wjmh.210055</ArticleId><ArticleId IdType="pmc">PMC8255400</ArticleId><ArticleId IdType="pubmed">33988001</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas N, et al. The underlying sex differences in neuroendocrine adaptations relevant to myalgic encephalomyelitis chronic fatigue syndrome. Front. Neuroendocrinol. 2022;66:100995. doi: 10.1016/j.yfrne.2022.100995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yfrne.2022.100995</ArticleId><ArticleId IdType="pubmed">35421511</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlow BL, et al. Reproductive correlates of chronic fatigue syndrome. Am. J. Med. 1998;105:94S&#x2013;99S. doi: 10.1016/S0002-9343(98)00173-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(98)00173-9</ArticleId><ArticleId IdType="pubmed">9790489</ArticleId></ArticleIdList></Reference><Reference><Citation>Korszun A, et al. Follicular phase hypothalamic-pituitary-gonadal axis function in women with fibromyalgia and chronic fatigue syndrome. J. Rheumatol. 2000;27:1526&#x2013;1530.</Citation><ArticleIdList><ArticleId IdType="pubmed">10852283</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares MN, et al. Skeletal muscle alterations in patients with acute COVID-19 and post-acute sequelae of COVID-19. J. Cachexia Sarcopenia Muscle. 2022;13:11&#x2013;22. doi: 10.1002/jcsm.12896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12896</ArticleId><ArticleId IdType="pmc">PMC8818659</ArticleId><ArticleId IdType="pubmed">34997689</ArticleId></ArticleIdList></Reference><Reference><Citation>Gobbi M, et al. Skeletal muscle mass, sarcopenia and rehabilitation outcomes in post-acute COVID-19 patients. J. Clin. Med. 2021;10:5623. doi: 10.3390/jcm10235623.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10235623</ArticleId><ArticleId IdType="pmc">PMC8658326</ArticleId><ArticleId IdType="pubmed">34884325</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, et al. Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Nat. Med. 2023;29:226&#x2013;235. doi: 10.1038/s41591-022-02116-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02116-3</ArticleId><ArticleId IdType="pmc">PMC9873564</ArticleId><ArticleId IdType="pubmed">36456834</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva CC, et al. Muscle dysfunction in the long coronavirus disease 2019 syndrome: pathogenesis and clinical approach. Rev. Med. Virol. 2022;32:e2355. doi: 10.1002/rmv.2355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2355</ArticleId><ArticleId IdType="pmc">PMC9111061</ArticleId><ArticleId IdType="pubmed">35416359</ArticleId></ArticleIdList></Reference><Reference><Citation>Martone AM, et al. Sarcopenia as potential biological substrate of long COVID-19 syndrome: prevalence, clinical features, and risk factors. J. Cachexia Sarcopenia Muscle. 2022;13:1974&#x2013;1982. doi: 10.1002/jcsm.12931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12931</ArticleId><ArticleId IdType="pmc">PMC9349974</ArticleId><ArticleId IdType="pubmed">35698920</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahlgren C, et al. Rehabilitation needs following COVID-19: five-month post-discharge clinical follow-up of individuals with concerning self-reported symptoms. EClinicalMedicine. 2022;43:101219. doi: 10.1016/j.eclinm.2021.101219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101219</ArticleId><ArticleId IdType="pmc">PMC8645256</ArticleId><ArticleId IdType="pubmed">34901798</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F, Guneri FD, Kardes S. Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin. Rheumatol. 2022;41:289&#x2013;296. doi: 10.1007/s10067-021-05942-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05942-x</ArticleId><ArticleId IdType="pmc">PMC8553494</ArticleId><ArticleId IdType="pubmed">34713356</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, et al. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study. Lancet Respir. Med. 2022;10:715&#x2013;724. doi: 10.1016/S2213-2600(22)00169-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00169-2</ArticleId><ArticleId IdType="pmc">PMC9197249</ArticleId><ArticleId IdType="pubmed">35714658</ArticleId></ArticleIdList></Reference><Reference><Citation>Disser NP, et al. Musculoskeletal consequences of COVID-19. J. Bone Joint Surg. Am. 2020;102:1197&#x2013;1204. doi: 10.2106/JBJS.20.00847.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.20.00847</ArticleId><ArticleId IdType="pmc">PMC7508274</ArticleId><ArticleId IdType="pubmed">32675661</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschman T, et al. Association between SARS-CoV-2 infection and immune-mediated myopathy in patients who have died. JAMA Neurol. 2021;78:948&#x2013;960. doi: 10.1001/jamaneurol.2021.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.2004</ArticleId><ArticleId IdType="pubmed">34115106</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh J, et al. Skeletal muscle and peripheral nerve histopathology in COVID-19. Neurology. 2021;97:e849&#x2013;e858. doi: 10.1212/WNL.0000000000012344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012344</ArticleId><ArticleId IdType="pubmed">34099523</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper JE, et al. Muscle biopsy findings in a case of SARS-CoV-2-associated muscle injury. J. Neuropathol. Exp. Neurol. 2021;80:377&#x2013;378. doi: 10.1093/jnen/nlaa155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlaa155</ArticleId><ArticleId IdType="pmc">PMC7799012</ArticleId><ArticleId IdType="pubmed">33355335</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg. Microbes Infect. 2020;9:1123&#x2013;1130. doi: 10.1080/22221751.2020.1770129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1770129</ArticleId><ArticleId IdType="pmc">PMC7473317</ArticleId><ArticleId IdType="pubmed">32475230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong SWX, et al. Persistent symptoms and association with inflammatory cytokine signatures in recovered coronavirus disease 2019 patients. Open Forum. Infect. Dis. 2021;8:ofab156. doi: 10.1093/ofid/ofab156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab156</ArticleId><ArticleId IdType="pmc">PMC8083585</ArticleId><ArticleId IdType="pubmed">34095336</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Girolamo FG, et al. Skeletal muscle in hypoxia and inflammation: insights on the COVID-19 pandemic. Front. Nutr. 2022;9:865402. doi: 10.3389/fnut.2022.865402.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.865402</ArticleId><ArticleId IdType="pmc">PMC9072827</ArticleId><ArticleId IdType="pubmed">35529457</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoja O, et al. Clinical characteristics and mechanisms of musculoskeletal pain in long COVID. J. Pain Res. 2022;15:1729&#x2013;1748. doi: 10.2147/JPR.S365026.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S365026</ArticleId><ArticleId IdType="pmc">PMC9212788</ArticleId><ArticleId IdType="pubmed">35747600</ArticleId></ArticleIdList></Reference><Reference><Citation>Herridge MS, et al. Functional disability 5 years after acute respiratory distress syndrome. N. Engl. J. Med. 2011;364:1293&#x2013;1304. doi: 10.1056/NEJMoa1011802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1011802</ArticleId><ArticleId IdType="pubmed">21470008</ArticleId></ArticleIdList></Reference><Reference><Citation>Paneroni M, et al. Muscle strength and physical performance in patients without previous disabilities recovering from COVID-19 pneumonia. Am. J. Phys. Med. Rehabil. 2021;100:105&#x2013;109. doi: 10.1097/PHM.0000000000001641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001641</ArticleId><ArticleId IdType="pubmed">33181531</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Aerde N, et al. Intensive care unit acquired muscle weakness in COVID-19 patients. Intensive Care Med. 2020;46:2083&#x2013;2085. doi: 10.1007/s00134-020-06244-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06244-7</ArticleId><ArticleId IdType="pmc">PMC7520507</ArticleId><ArticleId IdType="pubmed">32986233</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, et al. A mitofusin 2/HIF1alpha axis sets a maturation checkpoint in regenerating skeletal muscle. J. Clin. Invest. 2022;132:e161638. doi: 10.1172/JCI161638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI161638</ArticleId><ArticleId IdType="pmc">PMC9711883</ArticleId><ArticleId IdType="pubmed">36125902</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375:1122&#x2013;1127. doi: 10.1126/science.abm8108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss C, et al. Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19. J. Med. Virol. 2023;95:e28364. doi: 10.1002/jmv.28364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28364</ArticleId><ArticleId IdType="pmc">PMC9878213</ArticleId><ArticleId IdType="pubmed">36458566</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruffieux H, et al. A patient-centric modeling framework captures recovery from SARS-CoV-2 infection. Nat. Immunol. 2023;24:349&#x2013;358. doi: 10.1038/s41590-022-01380-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01380-2</ArticleId><ArticleId IdType="pmc">PMC9892000</ArticleId><ArticleId IdType="pubmed">36717723</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A, David P, Arnheim D, Shoenfeld Y. The autonomic aspects of the post-COVID19 syndrome. Autoimmun. Rev. 2022;21:103071. doi: 10.1016/j.autrev.2022.103071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2022.103071</ArticleId><ArticleId IdType="pmc">PMC8848724</ArticleId><ArticleId IdType="pubmed">35182777</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallmann E, et al. IgG autoantibodies against ACE2 in SARS-CoV-2 infected patients. J. Med. Virol. 2023;95:e28273. doi: 10.1002/jmv.28273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28273</ArticleId><ArticleId IdType="pmc">PMC9877908</ArticleId><ArticleId IdType="pubmed">36324055</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K, et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur. Respir. J. 2023;61:2200970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, et al. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. 2022;20:26. doi: 10.1186/s12916-021-02228-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J. Infect. Dis. 2021;224:1839&#x2013;1848. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson RC, et al. Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae. Nat. Med. 2023;29:236&#x2013;246. doi: 10.1038/s41591-022-02107-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02107-4</ArticleId><ArticleId IdType="pmc">PMC9873574</ArticleId><ArticleId IdType="pubmed">36482101</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott NA, et al. Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID. Eur. Respir. J. 2023;61:2202226. doi: 10.1183/13993003.02226-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02226-2022</ArticleId><ArticleId IdType="pmc">PMC10040898</ArticleId><ArticleId IdType="pubmed">36922030</ArticleId></ArticleIdList></Reference><Reference><Citation>Sneller MC, et al. A longitudinal study of COVID-19 sequelae and immunity: baseline findings. Ann. Intern. Med. 2022;175:969&#x2013;979. doi: 10.7326/M21-4905.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-4905</ArticleId><ArticleId IdType="pmc">PMC9128805</ArticleId><ArticleId IdType="pubmed">35605238</ArticleId></ArticleIdList></Reference><Reference><Citation>Fietsam AC, Bryant AD, Rudroff T. Fatigue and perceived fatigability, not objective fatigability, are prevalent in people with post-COVID-19. Exp. Brain Res. 2023;241:211&#x2013;219. doi: 10.1007/s00221-022-06518-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00221-022-06518-0</ArticleId><ArticleId IdType="pmc">PMC9735153</ArticleId><ArticleId IdType="pubmed">36462035</ArticleId></ArticleIdList></Reference><Reference><Citation>Kachaner A, et al. Somatic symptom disorder in patients with post-COVID-19 neurological symptoms: a preliminary report from the somatic study (somatic symptom disorder triggered by COVID-19) J. Neurol. Neurosurg. Psychiatry. 2022;93:1174&#x2013;1180. doi: 10.1136/jnnp-2021-327899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-327899</ArticleId><ArticleId IdType="pubmed">36008115</ArticleId></ArticleIdList></Reference><Reference><Citation>Horn M, et al. Persistent physical symptoms after COVID-19 infection and the risk of somatic symptom disorder. J. Psychosom. Res. 2023;166:111172. doi: 10.1016/j.jpsychores.2023.111172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2023.111172</ArticleId><ArticleId IdType="pmc">PMC9876030</ArticleId><ArticleId IdType="pubmed">36736191</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J, et al. Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern. Med. 2022;182:19&#x2013;25. doi: 10.1001/jamainternmed.2021.6454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.6454</ArticleId><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischer M, et al. Post-COVID-19 syndrome is rarely associated with damage of the nervous system: findings from a prospective observational cohort study in 171 patients. Neurol. Ther. 2022;11:1637&#x2013;1657. doi: 10.1007/s40120-022-00395-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40120-022-00395-z</ArticleId><ArticleId IdType="pmc">PMC9417089</ArticleId><ArticleId IdType="pubmed">36028604</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawke LD, et al. Interventions for mental health, cognition, and psychological wellbeing in long COVID: a systematic review of registered trials. Psychol. Med. 2022;52:2426&#x2013;2440. doi: 10.1017/S0033291722002203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291722002203</ArticleId><ArticleId IdType="pmc">PMC9300978</ArticleId><ArticleId IdType="pubmed">35768406</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusdottir I, et al. Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study. Lancet Public Health. 2022;7:e406&#x2013;e416. doi: 10.1016/S2468-2667(22)00042-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(22)00042-1</ArticleId><ArticleId IdType="pmc">PMC8920517</ArticleId><ArticleId IdType="pubmed">35298894</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. MMWR Morb. Mortal Wkly Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders C, Sperling S, Bendstrup E. A new paradigm is needed to explain long COVID. Lancet Respir. Med. 2023;11:e12&#x2013;e13. doi: 10.1016/S2213-2600(22)00501-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00501-X</ArticleId><ArticleId IdType="pubmed">36620963</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav. Immun. 2020;89:594&#x2013;600. doi: 10.1016/j.bbi.2020.07.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CP, et al. Long COVID and long chain fatty acids (LCFAs): psychoneuroimmunity implication of omega-3 LCFAs in delayed consequences of COVID-19. Brain Behav. Immun. 2022;103:19&#x2013;27. doi: 10.1016/j.bbi.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC8977215</ArticleId><ArticleId IdType="pubmed">35390469</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-a systematic review and meta-analysis. J. Med. Virol. 2022;94:253&#x2013;262. doi: 10.1002/jmv.27309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemogne C, Gouraud C, Pitron V, Ranque B. Why the hypothesis of psychological mechanisms in long COVID is worth considering. J. Psychosom. Res. 2023;165:111135. doi: 10.1016/j.jpsychores.2022.111135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2022.111135</ArticleId><ArticleId IdType="pmc">PMC9825049</ArticleId><ArticleId IdType="pubmed">36623391</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne EA. Understanding long COVID: nosology, social attitudes and stigma. Brain Behav. Immun. 2022;99:17&#x2013;24. doi: 10.1016/j.bbi.2021.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.09.012</ArticleId><ArticleId IdType="pubmed">34563621</ArticleId></ArticleIdList></Reference><Reference><Citation>Fava GA, Cosci F, Sonino N. Current psychosomatic practice. Psychother. Psychosom. 2017;86:13&#x2013;30. doi: 10.1159/000448856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000448856</ArticleId><ArticleId IdType="pubmed">27884006</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantelic M, et al. The prevalence of stigma in a UK community survey of people with lived experience of long COVID. Lancet. 2022;400:S84. doi: 10.1016/S0140-6736(22)02294-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)02294-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Satterfield BA, Bhatt DL, Gersh BJ. Cardiac involvement in the long-term implications of COVID-19. Nat. Rev. Cardiol. 2022;19:332&#x2013;341. doi: 10.1038/s41569-021-00631-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-021-00631-3</ArticleId><ArticleId IdType="pmc">PMC8532434</ArticleId><ArticleId IdType="pubmed">34686843</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco JR, et al. Pulmonary long-term consequences of COVID-19 infections after hospital discharge. Clin. Microbiol. Infect. 2021;27:892&#x2013;896. doi: 10.1016/j.cmi.2021.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.02.019</ArticleId><ArticleId IdType="pmc">PMC7920814</ArticleId><ArticleId IdType="pubmed">33662544</ArticleId></ArticleIdList></Reference><Reference><Citation>Bungenberg J, et al. Long COVID-19: objectifying most self-reported neurological symptoms. Ann. Clin. Transl. Neurol. 2022;9:141&#x2013;154. doi: 10.1002/acn3.51496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51496</ArticleId><ArticleId IdType="pmc">PMC8862437</ArticleId><ArticleId IdType="pubmed">35060361</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, et al. (18)F-FDG brain PET hypometabolism in patients with long COVID. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Dressing A, et al. Neuropsychologic profiles and cerebral glucose metabolism in neurocognitive long COVID syndrome. J. Nucl. Med. 2022;63:1058&#x2013;1063. doi: 10.2967/jnumed.121.262677.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.262677</ArticleId><ArticleId IdType="pmc">PMC9258569</ArticleId><ArticleId IdType="pubmed">34649946</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannos P, Prokopidis K. Gut dysbiosis and long COVID-19: feeling gutted. J. Med. Virol. 2022;94:2917&#x2013;2918. doi: 10.1002/jmv.27684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27684</ArticleId><ArticleId IdType="pmc">PMC9088471</ArticleId><ArticleId IdType="pubmed">35233795</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Q, et al. Faecal microbiome-based machine learning for multi-class disease diagnosis. Nat. Commun. 2022;13:6818. doi: 10.1038/s41467-022-34405-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34405-3</ArticleId><ArticleId IdType="pmc">PMC9649010</ArticleId><ArticleId IdType="pubmed">36357393</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran JP, et al. Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID. JCI Insight. 2021;6:e152346. doi: 10.1172/jci.insight.152346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.152346</ArticleId><ArticleId IdType="pmc">PMC8564890</ArticleId><ArticleId IdType="pubmed">34403368</ArticleId></ArticleIdList></Reference><Reference><Citation>Bizjak DA, et al. Kynurenine serves as useful biomarker in acute, long- and post-COVID-19 diagnostics. Front. Immunol. 2022;13:1004545. doi: 10.3389/fimmu.2022.1004545.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1004545</ArticleId><ArticleId IdType="pmc">PMC9537769</ArticleId><ArticleId IdType="pubmed">36211365</ArticleId></ArticleIdList></Reference><Reference><Citation>Guasp M, et al. CSF biomarkers in COVID-19 associated encephalopathy and encephalitis predict long-term outcome. Front. Immunol. 2022;13:866153. doi: 10.3389/fimmu.2022.866153.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.866153</ArticleId><ArticleId IdType="pmc">PMC9035899</ArticleId><ArticleId IdType="pubmed">35479062</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson BA, et al. Plasma biomarkers of neuropathogenesis in hospitalized patients with COVID-19 and those with postacute sequelae of SARS-CoV-2 infection. Neurol. Neuroimmunol. Neuroinflamm. 2022;9:e1151. doi: 10.1212/NXI.0000000000001151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001151</ArticleId><ArticleId IdType="pmc">PMC8901169</ArticleId><ArticleId IdType="pubmed">35256481</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, et al. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav. Immun. 2021;94:138&#x2013;147. doi: 10.1016/j.bbi.2021.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel MA, et al. Elevated vascular transformation blood biomarkers in long-COVID indicate angiogenesis as a key pathophysiological mechanism. Mol Med. 2022;28:122. doi: 10.1186/s10020-022-00548-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-022-00548-8</ArticleId><ArticleId IdType="pmc">PMC9549814</ArticleId><ArticleId IdType="pubmed">36217108</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. SARS-CoV-2 and mitochondrial proteins in neural-derived exosomes of COVID-19. Ann. Neurol. 2022;91:772&#x2013;781. doi: 10.1002/ana.26350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26350</ArticleId><ArticleId IdType="pmc">PMC9082480</ArticleId><ArticleId IdType="pubmed">35285072</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz MAF, et al. Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome. Front. Cell Infect. Microbiol. 2022;12:922422. doi: 10.3389/fcimb.2022.922422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.922422</ArticleId><ArticleId IdType="pmc">PMC9279918</ArticleId><ArticleId IdType="pubmed">35846757</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B, et al. Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations. Cells. 2021;10:386. doi: 10.3390/cells10020386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020386</ArticleId><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ, et al. Inflammatory and vascular biomarkers in post-COVID-19 syndrome: a systematic review and meta-analysis of over 20 biomarkers. Rev. Med. Virol. 2023;33:e2424. doi: 10.1002/rmv.2424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2424</ArticleId><ArticleId IdType="pubmed">36708022</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteller M. Non-coding RNAs in human disease. Nat. Rev. Genet. 2011;12:861&#x2013;874. doi: 10.1038/nrg3074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3074</ArticleId><ArticleId IdType="pubmed">22094949</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q, et al. Identification of a SARS-CoV-2 virus-encoded small non-coding RNA in association with the neurological disorders in COVID-19 patients. Signal Transduct. Target Ther. 2022;7:107. doi: 10.1038/s41392-022-00969-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00969-1</ArticleId><ArticleId IdType="pmc">PMC8967939</ArticleId><ArticleId IdType="pubmed">35361748</ArticleId></ArticleIdList></Reference><Reference><Citation>Donyavi T, et al. Acute and post-acute phase of COVID-19: analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC. Int. Immunopharmacol. 2021;97:107641. doi: 10.1016/j.intimp.2021.107641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107641</ArticleId><ArticleId IdType="pmc">PMC8023203</ArticleId><ArticleId IdType="pubmed">33895478</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE. COVID-19 rapid guideline: managing the long-term effects of COVID-19, https://www.ncbi.nlm.nih.gov/books/NBK567261/ (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee YJ, et al. Clinical trials on the pharmacological treatment of long COVID: a systematic review. J. Med. Virol. 2023;95:e28289. doi: 10.1002/jmv.28289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28289</ArticleId><ArticleId IdType="pmc">PMC9878018</ArticleId><ArticleId IdType="pubmed">36349400</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, et al. ESCMID rapid guidelines for assessment and management of long COVID. Clin. Microbiol. Infect. 2022;28:955&#x2013;972. doi: 10.1016/j.cmi.2022.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="pubmed">35182760</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanfleteren L, Spruit MA, Wouters EFM, Franssen FME. Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respir. Med. 2016;4:911&#x2013;924. doi: 10.1016/S2213-2600(16)00097-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(16)00097-7</ArticleId><ArticleId IdType="pubmed">27264777</ArticleId></ArticleIdList></Reference><Reference><Citation>Nopp S, et al. Outpatient pulmonary rehabilitation in patients with long COVID improves exercise capacity, functional status, dyspnea, fatigue, and quality of life. Respiration. 2022;101:593&#x2013;601. doi: 10.1159/000522118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000522118</ArticleId><ArticleId IdType="pmc">PMC9059007</ArticleId><ArticleId IdType="pubmed">35203084</ArticleId></ArticleIdList></Reference><Reference><Citation>McNarry MA, et al. Inspiratory muscle training enhances recovery post-COVID-19: a randomised controlled trial. Eur. Respir. J. 2022;60:2103101. doi: 10.1183/13993003.03101-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03101-2021</ArticleId><ArticleId IdType="pmc">PMC8900538</ArticleId><ArticleId IdType="pubmed">35236727</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip KEJ, et al. An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trial. Lancet Respir. Med. 2022;10:851&#x2013;862. doi: 10.1016/S2213-2600(22)00125-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00125-4</ArticleId><ArticleId IdType="pmc">PMC9045747</ArticleId><ArticleId IdType="pubmed">35489367</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi L, et al. Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial. EBioMedicine. 2022;75:103789. doi: 10.1016/j.ebiom.2021.103789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103789</ArticleId><ArticleId IdType="pmc">PMC8709782</ArticleId><ArticleId IdType="pubmed">34963099</ArticleId></ArticleIdList></Reference><Reference><Citation>Besnier F, et al. Cardiopulmonary rehabilitation in long-COVID-19 Patients with persistent breathlessness and fatigue: the COVID-Rehab study. Int. J. Environ. Res. Public Health. 2022;19:4133. doi: 10.3390/ijerph19074133.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19074133</ArticleId><ArticleId IdType="pmc">PMC8998214</ArticleId><ArticleId IdType="pubmed">35409815</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandi E, Ripplinger CM. Antiarrhythmic mechanisms of beta blocker therapy. Pharmacol. Res. 2019;146:104274. doi: 10.1016/j.phrs.2019.104274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2019.104274</ArticleId><ArticleId IdType="pmc">PMC6679787</ArticleId><ArticleId IdType="pubmed">31100336</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management. J. Intern. Med. 2019;285:352&#x2013;366. doi: 10.1111/joim.12852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12852</ArticleId><ArticleId IdType="pubmed">30372565</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE. Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management, https://www.ncbi.nlm.nih.gov/books/NBK579533/ (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Cash A, Kaufman DL. Oxaloacetate treatment for mental and physical fatigue in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long-COVID fatigue patients: a non-randomized controlled clinical trial. J. Transl. Med. 2022;20:295. doi: 10.1186/s12967-022-03488-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03488-3</ArticleId><ArticleId IdType="pmc">PMC9238249</ArticleId><ArticleId IdType="pubmed">35764955</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins T, et al. Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention. Clin. Med. 2021;21:e629&#x2013;e632. doi: 10.7861/clinmed.2021-0462.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2021-0462</ArticleId><ArticleId IdType="pmc">PMC8806311</ArticleId><ArticleId IdType="pubmed">34862223</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirelli U, et al. Fatigue in post-acute sequelae of SARS-CoV2 (PASC) treated with oxygen-ozone autohemotherapy - preliminary results on 100 patients. Eur. Rev. Med. Pharmacol. Sci. 2021;25:5871&#x2013;5875.</Citation><ArticleIdList><ArticleId IdType="pubmed">34604980</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackett JW, et al. Decreased gut microbiome tryptophan metabolism and serotonergic signaling in patients with persistent mental health and gastrointestinal symptoms after COVID-19. Clin. Transl. Gastroenterol. 2022;13:e00524. doi: 10.14309/ctg.0000000000000524.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ctg.0000000000000524</ArticleId><ArticleId IdType="pmc">PMC9624499</ArticleId><ArticleId IdType="pubmed">36049050</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, et al. Gut microbiota-derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID-19: an open-label pilot study. J. Gastroenterol. Hepatol. 2022;37:823&#x2013;831. doi: 10.1111/jgh.15796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.15796</ArticleId><ArticleId IdType="pmc">PMC9115073</ArticleId><ArticleId IdType="pubmed">35170078</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimarco V, et al. Endothelial dysfunction in long-COVID: new insights from the nationwide multicenter LINCOLN study. Pharmacol. Res. 2022;185:106486. doi: 10.1016/j.phrs.2022.106486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2022.106486</ArticleId><ArticleId IdType="pmc">PMC9531936</ArticleId><ArticleId IdType="pubmed">36206959</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzo R, et al. Combining L-Arginine with vitamin C improves long-COVID symptoms: the LINCOLN survey. Pharmacol. Res. 2022;183:106360. doi: 10.1016/j.phrs.2022.106360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2022.106360</ArticleId><ArticleId IdType="pmc">PMC9295384</ArticleId><ArticleId IdType="pubmed">35868478</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitt B, et al. Repurposing low-dose naltrexone for the prevention and treatment of immunothrombosis in COVID-19. Eur. Heart J. Cardiovasc. Pharmacother. 2022;8:402&#x2013;405. doi: 10.1093/ehjcvp/pvac014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcvp/pvac014</ArticleId><ArticleId IdType="pmc">PMC8903502</ArticleId><ArticleId IdType="pubmed">35179184</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiler CR, et al. AAAAI mast cell disorders committee work group report: mast cell activation syndrome (MCAS) diagnosis and management. J. Allergy Clin. Immunol. 2019;144:883&#x2013;896. doi: 10.1016/j.jaci.2019.08.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2019.08.023</ArticleId><ArticleId IdType="pubmed">31476322</ArticleId></ArticleIdList></Reference><Reference><Citation>Noda Y, et al. Real world research on transcranial magnetic stimulation treatment strategies for neuropsychiatric symptoms with long-COVID in Japan. Asian J. Psychiatr. 2023;81:103438. doi: 10.1016/j.ajp.2022.103438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2022.103438</ArticleId><ArticleId IdType="pmc">PMC9795803</ArticleId><ArticleId IdType="pubmed">36610206</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, et al. Efficacy of corticosteroid therapy in the treatment of long-lasting olfactory disorders in COVID-19 patients. Rhinology. 2021;59:21&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">33290446</ArticleId></ArticleIdList></Reference><Reference><Citation>De Luca P, et al. Effect of ultra-micronized palmitoylethanolamide and luteolin on olfaction and memory in patients with long COVID: results of a longitudinal study. Cells. 2022;11:2552. doi: 10.3390/cells11162552.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11162552</ArticleId><ArticleId IdType="pmc">PMC9406356</ArticleId><ArticleId IdType="pubmed">36010630</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanthanna H, Nelson AM, Kissoon N, Narouze S. The COVID-19 pandemic and its consequences for chronic pain: a narrative review. Anaesthesia. 2022;77:1039&#x2013;1050. doi: 10.1111/anae.15801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15801</ArticleId><ArticleId IdType="pmc">PMC9350079</ArticleId><ArticleId IdType="pubmed">35848380</ArticleId></ArticleIdList></Reference><Reference><Citation>Korompoki E, et al. Epidemiology and organ specific sequelae of post-acute COVID19: a narrative review. J. Infect. 2021;83:1&#x2013;16. doi: 10.1016/j.jinf.2021.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.05.004</ArticleId><ArticleId IdType="pmc">PMC8118709</ArticleId><ArticleId IdType="pubmed">33992686</ArticleId></ArticleIdList></Reference><Reference><Citation>Fancourt D, Steptoe A, Bu F. Psychological consequences of long COVID: comparing trajectories of depressive and anxiety symptoms before and after contracting SARS-CoV-2 between matched long- and short-COVID groups. Br. J. Psychiatry. 2023;222:74&#x2013;81. doi: 10.1192/bjp.2022.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.2022.155</ArticleId><ArticleId IdType="pmc">PMC7614126</ArticleId><ArticleId IdType="pubmed">36458509</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharaeva Z, et al. Fermented Carica papaya and Morinda citrifolia as perspective food supplements for the treatment of post-COVID symptoms: randomized placebo-controlled clinical laboratory study. Nutrients. 2022;14:2203. doi: 10.3390/nu14112203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14112203</ArticleId><ArticleId IdType="pmc">PMC9182401</ArticleId><ArticleId IdType="pubmed">35684003</ArticleId></ArticleIdList></Reference><Reference><Citation>Motti ML, et al. The role of nutrients in prevention, treatment and post-coronavirus disease-2019 (COVID-19) Nutrients. 2022;14:1000. doi: 10.3390/nu14051000.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14051000</ArticleId><ArticleId IdType="pmc">PMC8912782</ArticleId><ArticleId IdType="pubmed">35267974</ArticleId></ArticleIdList></Reference><Reference><Citation>Suran M. VA finds nirmatrelvir associated with lower risk of long COVID. JAMA. 2022;328:2386.</Citation><ArticleIdList><ArticleId IdType="pubmed">36573990</ArticleId></ArticleIdList></Reference><Reference><Citation>Oronsky B, et al. A review of persistent post-COVID syndrome (PPCS) Clin. Rev. Allergy Immunol. 2023;64:66&#x2013;74. doi: 10.1007/s12016-021-08848-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08848-3</ArticleId><ArticleId IdType="pmc">PMC7896544</ArticleId><ArticleId IdType="pubmed">33609255</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond J, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19. N. Engl. J. Med. 2022;386:1397&#x2013;1408. doi: 10.1056/NEJMoa2118542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2118542</ArticleId><ArticleId IdType="pmc">PMC8908851</ArticleId><ArticleId IdType="pubmed">35172054</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi WL, et al. Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J. Clin. 2019;69:127&#x2013;157. doi: 10.3322/caac.21552.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21552</ArticleId><ArticleId IdType="pmc">PMC6403009</ArticleId><ArticleId IdType="pubmed">30720861</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang H, et al. Evaluation and accurate diagnoses of pediatric diseases using artificial intelligence. Nat. Med. 2019;25:433&#x2013;438. doi: 10.1038/s41591-018-0335-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0335-9</ArticleId><ArticleId IdType="pubmed">30742121</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, et al. Development and validation of an abnormality-derived deep-learning diagnostic system for major respiratory diseases. npj Digit Med. 2022;5:124. doi: 10.1038/s41746-022-00648-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-022-00648-z</ArticleId><ArticleId IdType="pmc">PMC9395860</ArticleId><ArticleId IdType="pubmed">35999467</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, et al. Clinically applicable AI system for accurate diagnosis, quantitative measurements, and prognosis of COVID-19 pneumonia using computed tomography. Cell. 2020;181:1423&#x2013;1433.e1411. doi: 10.1016/j.cell.2020.04.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.045</ArticleId><ArticleId IdType="pmc">PMC7196900</ArticleId><ArticleId IdType="pubmed">32416069</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, et al. A deep-learning pipeline for the diagnosis and discrimination of viral, non-viral and COVID-19 pneumonia from chest X-ray images. Nat. Biomed. Eng. 2021;5:509&#x2013;521. doi: 10.1038/s41551-021-00704-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41551-021-00704-1</ArticleId><ArticleId IdType="pmc">PMC7611049</ArticleId><ArticleId IdType="pubmed">33859385</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi E, et al. Investigation of liquid biopsy analytes in peripheral blood of individuals after SARS-CoV-2 infection. EBioMedicine. 2023;90:104519. doi: 10.1016/j.ebiom.2023.104519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104519</ArticleId><ArticleId IdType="pmc">PMC10008671</ArticleId><ArticleId IdType="pubmed">36921564</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, et al. Investigating phenotypes of pulmonary COVID-19 recovery: a longitudinal observational prospective multicenter trial. Elife. 2022;11:e72500. doi: 10.7554/eLife.72500.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.72500</ArticleId><ArticleId IdType="pmc">PMC8896831</ArticleId><ArticleId IdType="pubmed">35131031</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, et al. Identifying who has long COVID in the USA: a machine learning approach using N3C data. Lancet Digit Health. 2022;4:e532&#x2013;e541. doi: 10.1016/S2589-7500(22)00048-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(22)00048-6</ArticleId><ArticleId IdType="pmc">PMC9110014</ArticleId><ArticleId IdType="pubmed">35589549</ArticleId></ArticleIdList></Reference><Reference><Citation>Hultstrom M, et al. Dehydration is associated with production of organic osmolytes and predicts physical long-term symptoms after COVID-19: a multicenter cohort study. Crit. Care. 2022;26:322. doi: 10.1186/s13054-022-04203-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-04203-w</ArticleId><ArticleId IdType="pmc">PMC9585783</ArticleId><ArticleId IdType="pubmed">36271419</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese JT, et al. Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes. EBioMedicine. 2023;87:104413. doi: 10.1016/j.ebiom.2022.104413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104413</ArticleId><ArticleId IdType="pmc">PMC9769411</ArticleId><ArticleId IdType="pubmed">36563487</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes SE, et al. Development and validation of the symptom burden questionnaire for long COVID (SBQ-LC): rasch analysis. BMJ. 2022;377:e070230. doi: 10.1136/bmj-2022-070230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-070230</ArticleId><ArticleId IdType="pmc">PMC9043395</ArticleId><ArticleId IdType="pubmed">35477524</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran VT, et al. Development and validation of the long coronavirus disease (COVID) symptom and impact tools: a set of patient-reported instruments constructed from patients&#x2019; lived experience. Clin. Infect Dis. 2022;74:278&#x2013;287. doi: 10.1093/cid/ciab352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab352</ArticleId><ArticleId IdType="pmc">PMC8135558</ArticleId><ArticleId IdType="pubmed">33912905</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, et al. The modified COVID-19 Yorkshire rehabilitation scale (C19-YRSm) patient-reported outcome measure for long COVID or post-COVID-19 syndrome. J. Med. Virol. 2022;94:4253&#x2013;4264. doi: 10.1002/jmv.27878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27878</ArticleId><ArticleId IdType="pmc">PMC9348420</ArticleId><ArticleId IdType="pubmed">35603810</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchino M, et al. Chest CT-based assessment of 1-year outcomes after moderate COVID-19 pneumonia. Radiology. 2022;305:479&#x2013;485. doi: 10.1148/radiol.220019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.220019</ArticleId><ArticleId IdType="pmc">PMC9619196</ArticleId><ArticleId IdType="pubmed">35536134</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, et al. Six-month follow-up chest CT findings after severe COVID-19 pneumonia. Radiology. 2021;299:E177&#x2013;E186. doi: 10.1148/radiol.2021203153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021203153</ArticleId><ArticleId IdType="pmc">PMC7841877</ArticleId><ArticleId IdType="pubmed">33497317</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerum TV, et al. Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19. Eur. Respir. J. 2021;57:2003448. doi: 10.1183/13993003.03448-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03448-2020</ArticleId><ArticleId IdType="pmc">PMC7736755</ArticleId><ArticleId IdType="pubmed">33303540</ArticleId></ArticleIdList></Reference><Reference><Citation>Luger AK, et al. Chest CT of lung injury 1 year after COVID-19 pneumonia: the CovILD study. Radiology. 2022;304:462&#x2013;470. doi: 10.1148/radiol.211670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.211670</ArticleId><ArticleId IdType="pmc">PMC8988857</ArticleId><ArticleId IdType="pubmed">35348379</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon JJ, et al. CT of post-acute lung complications of COVID-19. Radiology. 2021;301:E383&#x2013;E395. doi: 10.1148/radiol.2021211396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021211396</ArticleId><ArticleId IdType="pmc">PMC8369881</ArticleId><ArticleId IdType="pubmed">34374591</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, et al. Healthy outcomes of patients with COVID-19 two years after the infection: a prospective cohort study. Emerg. Microbes Infect. 2022;11:2680&#x2013;2688. doi: 10.1080/22221751.2022.2133639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2133639</ArticleId><ArticleId IdType="pmc">PMC9639507</ArticleId><ArticleId IdType="pubmed">36215047</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B, et al. CT lung abnormalities after COVID-19 at 3 months and 1 year after hospital discharge. Radiology. 2022;303:444&#x2013;454. doi: 10.1148/radiol.2021211746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021211746</ArticleId><ArticleId IdType="pmc">PMC8515207</ArticleId><ArticleId IdType="pubmed">34609195</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipkova J, et al. Artificial intelligence for multimodal data integration in oncology. Cancer Cell. 2022;40:1095&#x2013;1110. doi: 10.1016/j.ccell.2022.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2022.09.012</ArticleId><ArticleId IdType="pmc">PMC10655164</ArticleId><ArticleId IdType="pubmed">36220072</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao J, et al. Predicting gene mutation status via artificial intelligence technologies based on multimodal integration (MMI) to advance precision oncology. Semin. Cancer Biol. 2023;91:1&#x2013;15. doi: 10.1016/j.semcancer.2023.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2023.02.006</ArticleId><ArticleId IdType="pubmed">36801447</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehm KM, et al. Harnessing multimodal data integration to advance precision oncology. Nat. Rev. Cancer. 2022;22:114&#x2013;126. doi: 10.1038/s41568-021-00408-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41568-021-00408-3</ArticleId><ArticleId IdType="pmc">PMC8810682</ArticleId><ArticleId IdType="pubmed">34663944</ArticleId></ArticleIdList></Reference><Reference><Citation>Cauchemez S, Bosetti P. A reconstruction of early cryptic COVID spread. Nature. 2021;600:40&#x2013;41. doi: 10.1038/d41586-021-02989-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-02989-3</ArticleId><ArticleId IdType="pubmed">34725517</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucirka LM, et al. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. Ann. Intern. Med. 2020;173:262&#x2013;267. doi: 10.7326/M20-1495.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-1495</ArticleId><ArticleId IdType="pmc">PMC7240870</ArticleId><ArticleId IdType="pubmed">32422057</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos PG, et al. When to test for COVID-19 using real-time reverse transcriptase polymerase chain reaction: a systematic review. Int. J. Infect. Dis. 2022;123:58&#x2013;69. doi: 10.1016/j.ijid.2022.06.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.06.037</ArticleId><ArticleId IdType="pmc">PMC9233872</ArticleId><ArticleId IdType="pubmed">35760382</ArticleId></ArticleIdList></Reference><Reference><Citation>Davido B, et al. Predictors of nonseroconversion after SARS-CoV-2 infection. Emerg. Infect. Dis. 2022;28:492&#x2013;493. doi: 10.3201/eid2802.211971.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2802.211971</ArticleId><ArticleId IdType="pmc">PMC8798703</ArticleId><ArticleId IdType="pubmed">35076375</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Elslande J, et al. Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection. J. Clin. Virol. 2021;136:104765. doi: 10.1016/j.jcv.2021.104765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2021.104765</ArticleId><ArticleId IdType="pmc">PMC7891078</ArticleId><ArticleId IdType="pubmed">33636554</ArticleId></ArticleIdList></Reference><Reference><Citation>Toh ZQ, et al. Comparison of seroconversion in children and adults with mild COVID-19. JAMA Netw. Open. 2022;5:e221313. doi: 10.1001/jamanetworkopen.2022.1313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.1313</ArticleId><ArticleId IdType="pmc">PMC8908077</ArticleId><ArticleId IdType="pubmed">35262717</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks JJ, et al. Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Syst. Rev. 2020;6:CD013652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7387103</ArticleId><ArticleId IdType="pubmed">32584464</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson TM, et al. Coverage of CFS within U.S. medical schools. Univers. J. Public Health. 2013;1:177&#x2013;179. doi: 10.13189/ujph.2013.010404.</Citation><ArticleIdList><ArticleId IdType="doi">10.13189/ujph.2013.010404</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw BH, et al. The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey. J. Intern. Med. 2019;286:438&#x2013;448. doi: 10.1111/joim.12895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12895</ArticleId><ArticleId IdType="pmc">PMC6790699</ArticleId><ArticleId IdType="pubmed">30861229</ArticleId></ArticleIdList></Reference><Reference><Citation>Brigham E, et al. The Johns Hopkins Post-Acute COVID-19 Team (PACT): a multidisciplinary, collaborative, ambulatory framework supporting COVID-19 survivors. Am. J. Med. 2021;134:462&#x2013;467.e461. doi: 10.1016/j.amjmed.2020.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2020.12.009</ArticleId><ArticleId IdType="pmc">PMC7801819</ArticleId><ArticleId IdType="pubmed">33444589</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeloye D, et al. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease. Lancet Respir. Med. 2021;9:1467&#x2013;1478. doi: 10.1016/S2213-2600(21)00286-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00286-1</ArticleId><ArticleId IdType="pmc">PMC8372501</ArticleId><ArticleId IdType="pubmed">34416191</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, et al. Symptoms, complications and management of long COVID: a review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ, Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev. Med. Virol. 2022;32:e2315. doi: 10.1002/rmv.2315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2315</ArticleId><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>He ST, et al. Long COVID: the latest manifestations, mechanisms, and potential therapeutic interventions. MedComm. 2022;3:e196. doi: 10.1002/mco2.196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mco2.196</ArticleId><ArticleId IdType="pmc">PMC9732402</ArticleId><ArticleId IdType="pubmed">36514781</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>